logo

For the Inventor, By the Inventor

Incheon, South Korea

Zymedi Co., Ltd.


USPTO Granted Patents = 3



Forward Citations = 1

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Nam Hoon Kwon (3 out of 6 patents)

silverMedal Sunghoon Kim (2 out of 131 patents)

bronzeMedal Jin Young Lee (2 out of 23 patents)

4.  Kun Ho Kim (1 out of 1 patent)

5.  Hyunbo Shim (1 out of 3 patents)

6.  Daeyoung Han (1 out of 1 patent)

7.  Sunghoon Kim (1 out of 126 patents)


3 patents:

1. 11965038 - Pharmaceutical composition comprising antibody binding specifically to lysyl-tRNA synthetase N-terminus as effective ingredient for preventing or treating immune cell migration-related disease (2024-04-23),
2. 11685791 - Antibody binding specifically to N-terminal region of lysyl-tRNA synthetase exposed on cell membrane (2023-06-27),
3. 11378572 - Therapeutic agent for immune cell migration-caused disease and method for screening same (2022-07-05),
logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

3 Patents

#102 in Incheon, 402-040

#2,641 in South Korea

...
Incheon, South Korea

Zymedi Co., Ltd.

Forward Citations = 1

9 inventors:

goldMedal Nam Hoon Kwon (3 out of 6 patents)

silverMedal Sunghoon Kim (2 out of 131 patents)

bronzeMedal Jin Young Lee (2 out of 23 patents)

4.  Kun Ho Kim (1 out of 1 patent)

5.  Hyunbo Shim (1 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…